Rafik Karaman

[73] Wang, T.; Upponi, J.R. & Torchilin, V.P. (2012). Design of multifunctional non-viral gene vectors to overcome physiological barriers: Dilemmas and strategies. *Interna‐*

[74] Wang, Q., Jiang, W., Chen, Y., Liu, P., Sheng, C., Chen, S., Zhang, H., Pan, C., Gao, S. & Huang, W. (2014). *In Vivo* electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses*. J. Virol.*, Vol. 88, No. 4,

[75] Weaver, J.C. & Chizmadzhev, Y.A. (1996). Theory of electroporation: A review. *Bioe‐*

[76] Wells, D.J. (2010). Electroporation and ultrasound enhanced non-viral gene delivery

[77] Widera, G.; Austin, M.; Rabussay, D.; Goldbeck, C.; Barnett, S.W.; Chen, M.; Leung, L.; Otten, G.R.; Thudium, K.; Selby, M.J. & Ulmer, J.B. (2000). Increased DNA vaccine delivery and immunogenicity by electroporation *in vivo*. *J. Immunol.,* Vol. 164, No. 9,

[78] Yao, S.; Rana, S.; Liu, D.; Wise, G.E. (2009). Improvement of electroporation to deliver plasmid DNA into dental follicle cells. *Biotechnol. J.*; Vol. 4, No. 10, pp. 1488–1496 [79] Yen, H.H. & Scheerlinck, J.P. (2007). Co-delivery of plasmid-encoded cytokines mod‐ ulates the immune response to a DNA vaccine delivered by *in vivo* electroporation.

[80] Yuan, T.F. (2008). Vaccine submission with muscle electroporation. *Vaccine*, Vol. 26,

[81] Yuan, T.F. (2008). Vaccination by muscle electroporation: The injury helps. *Vaccine*,

[82] Zhou, Y.; Fang, F.; Chen, J.; Wang, H.; Chang, H.; Yang, Z.; Chen, Z. (2008). Electro‐ poration at low voltages enables DNA vaccine to provide protection against a lethal H5N1 avian influenza virus challenge in mice. *Intervirology*, Vol. 51, No. 4, pp.

*tional Journal of Pharmaceutics*, Vol. 427, No. 1, pp. 3-20

*lectrochemistry and Bioenergetics*, Vol. 41, No. 2, pp. 135-160

*in vitro* and *in vivo*. *Cell Biol. Toxicol.* Vol. 26, No. 1, pp. 21-28

pp. 1924-1934

398 Application of Nanotechnology in Drug Delivery

pp. 4635-4640

No. 15, pp.1805-1806

241-246

Vol. 26, No. 33, pp. 4105–4106

*Vaccine*, Vol. 25, No. 14, pp. 2575–2582

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/58404
